114 related articles for article (PubMed ID: 24303922)
1. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
[TBL] [Abstract][Full Text] [Related]
2. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation and functional implication of S100P in cancer.
Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
[TBL] [Abstract][Full Text] [Related]
4. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
5. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
[TBL] [Abstract][Full Text] [Related]
6. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
[TBL] [Abstract][Full Text] [Related]
7. S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer.
Tóthová V; Gibadulinová A
Acta Virol; 2013; 57(2):238-46. PubMed ID: 23600880
[TBL] [Abstract][Full Text] [Related]
8. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).
Arumugam T; Simeone DM; Schmidt AM; Logsdon CD
J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629
[TBL] [Abstract][Full Text] [Related]
9. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.
Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA
Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020
[TBL] [Abstract][Full Text] [Related]
10. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
[TBL] [Abstract][Full Text] [Related]
11. Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.
Jiang H; Hu H; Tong X; Jiang Q; Zhu H; Zhang S
J Cancer Res Clin Oncol; 2012 Jan; 138(1):1-9. PubMed ID: 21947242
[TBL] [Abstract][Full Text] [Related]
12. Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P.
Zhang D; Chen X; Xia H; Wang L; Zhao H; Xu B; Zhang A; Zhang W
BMC Cancer; 2020 Sep; 20(1):845. PubMed ID: 32883230
[TBL] [Abstract][Full Text] [Related]
13. S100P: a novel therapeutic target for cancer.
Arumugam T; Logsdon CD
Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
[TBL] [Abstract][Full Text] [Related]
14. Generation and characterization of a novel, permanently active S100P mutant.
Austermann J; Nazmi AR; Heil A; Fritz G; Kolinski M; Filipek S; Gerke V
Biochim Biophys Acta; 2009 Jun; 1793(6):1078-85. PubMed ID: 19111582
[TBL] [Abstract][Full Text] [Related]
15. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-dependent binding and activation of dormant ezrin by dimeric S100P.
Koltzscher M; Neumann C; König S; Gerke V
Mol Biol Cell; 2003 Jun; 14(6):2372-84. PubMed ID: 12808036
[TBL] [Abstract][Full Text] [Related]
17. S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.
Padilla L; Dakhel S; Hernández JL
Biochem Biophys Res Commun; 2014 Mar; 446(1):404-9. PubMed ID: 24613850
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
19. The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.
Meghnani V; Wagh A; Indurthi VS; Koladia M; Vetter SW; Law B; Leclerc E
Int J Biochem Cell Biol; 2014 Dec; 57():54-62. PubMed ID: 25310905
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
